FibroGen, Inc.FGENNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-142.43M
Near historical average
Average (9y)
$-156.79M
Historical baseline
Range
High:$-44.99M
Low:$-333.72M
CAGR
+8.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-142.43M | +53.3% |
| 2023 | $-305.20M | -7.9% |
| 2022 | $-282.82M | +15.3% |
| 2021 | $-333.72M | -103.1% |
| 2020 | $-164.28M | -214.0% |
| 2019 | $-52.31M | +23.7% |
| 2018 | $-68.56M | +34.5% |
| 2017 | $-104.75M | -132.8% |
| 2016 | $-44.99M | +34.6% |
| 2015 | $-68.83M | - |